Payment overview · 2025
General Payments
$47.17
2 reported records · 2 companies
Healthcare provider profile · identity verified
Jon A Raso, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · MOUNT BETHEL, PA · NPI 1609080175
Verified facts
What the public records show
CMS Open Payments records show Jon A Raso, M.D. received $47.17 in general payments during 2025 across 2 reported records.
Endo USA, Inc. accounted for 58.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 231 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Endo USA, Inc. | Unresolved — no canonical attribution shown | $27.61 | 58.5% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $19.56 | 41.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $47.17 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| XIAFLEX Normalized: xiaflex |
Biological | Endo USA, Inc. | $27.61 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $19.56 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $19.56 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 231 | exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 11 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
231 | 36 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1071 | 279 |
| Levothyroxine Sodium | Levothyroxine Sodium | 948 | 230 |
| Gabapentin | Gabapentin | 947 | 209 |
| Amlodipine Besylate | Amlodipine Besylate | 908 | 239 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 603 | 162 |
| Furosemide | Furosemide | 579 | 159 |
| Metformin Hcl | Metformin Hcl | 573 | 148 |
| Prednisone | Prednisone | 555 | 226 |
| Lisinopril | Lisinopril | 535 | 143 |
| Methylprednisolone | Methylprednisolone | 523 | 351 |
| Metoprolol Succinate | Metoprolol Succinate | 522 | 137 |
| Losartan Potassium | Losartan Potassium | 517 | 138 |
| Pantoprazole Sodium | Pantoprazole Sodium | 516 | 134 |
| Omeprazole | Omeprazole | 500 | 122 |
| Montelukast Sodium | Montelukast Sodium | 422 | 114 |
| Alprazolam | Alprazolam | 404 | 74 |
| Hydrochlorothiazide | Hydrochlorothiazide | 354 | 102 |
| Tamsulosin Hcl | Tamsulosin Hcl | 350 | 101 |
| Eliquis | Apixaban | 335 | 69 |
| Metoprolol Tartrate | Metoprolol Tartrate | 333 | 90 |
| Doxycycline Hyclate | Doxycycline Hyclate | 314 | 196 |
| Simvastatin | Simvastatin | 311 | 78 |
| Potassium Chloride | Potassium Chloride | 306 | 83 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 294 | 89 |
| Tramadol Hcl | Tramadol Hcl | 282 | 57 |
| Glimepiride | Glimepiride | 255 | 58 |
| Azithromycin | Azithromycin | 249 | 185 |
| Diclofenac Sodium | Diclofenac Sodium | 249 | 72 |
| Atenolol | Atenolol | 242 | 61 |
| Valsartan | Valsartan | 237 | 65 |
| Lorazepam | Lorazepam | 236 | 57 |
| Trazodone Hcl | Trazodone Hcl | 235 | 66 |
| Ozempic | Semaglutide | 231 | 36 |
| Escitalopram Oxalate | Escitalopram Oxalate | 226 | 51 |
| Famotidine | Famotidine | 207 | 63 |
| Allopurinol | Allopurinol | 205 | 52 |
| Buspirone Hcl | Buspirone Hcl | 203 | 42 |
| Ezetimibe | Ezetimibe | 203 | 59 |
| Sertraline Hcl | Sertraline Hcl | 197 | 49 |
| Quetiapine Fumarate | Quetiapine Fumarate | 182 | 35 |
| Cephalexin | Cephalexin | 180 | 83 |
| Clopidogrel | Clopidogrel Bisulfate | 178 | 54 |
| Meloxicam | Meloxicam | 176 | 49 |
| Xarelto | Rivaroxaban | 166 | 30 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 159 | 124 |
| Meclizine Hcl | Meclizine Hcl | 156 | 58 |
| Duloxetine Hcl | Duloxetine Hcl | 155 | 43 |
| Warfarin Sodium | Warfarin Sodium | 152 | 26 |
| Glipizide | Glipizide | 150 | 31 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 145 | 65 |
| Baclofen | Baclofen | 144 | 48 |
| Tizanidine Hcl | Tizanidine Hcl | 139 | 39 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 136 | 99 |
| Ondansetron Hcl | Ondansetron Hcl | 135 | 49 |
| Carvedilol | Carvedilol | 130 | 33 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 128 | 85 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 120 | 31 |
| Torsemide | Torsemide | 118 | 30 |
| Jardiance | Empagliflozin | 116 | 28 |
| Clonazepam | Clonazepam | 114 | 18 |
| Mirtazapine | Mirtazapine | 105 | 23 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 104 | 39 |
| Donepezil Hcl | Donepezil Hcl | 102 | 22 |
| Paroxetine Hcl | Paroxetine Hcl | 96 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 94 | 22 |
| Doxepin Hcl | Doxepin Hcl | 93 | 23 |
| Zolpidem Tartrate | Zolpidem Tartrate | 92 | 21 |
| Farxiga | Dapagliflozin Propanediol | 91 | 18 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 91 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 91 | 22 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 85 | 26 |
| Methocarbamol | Methocarbamol | 84 | 34 |
| Terazosin Hcl | Terazosin Hcl | 84 | 22 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 82 | 18 |
| Azelastine Hcl | Azelastine Hcl | 81 | 32 |
| Finasteride | Finasteride | 81 | 28 |
| Synthroid | Levothyroxine Sodium | 81 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 80 | 25 |
| Sucralfate | Sucralfate | 78 | 28 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 76 | 29 |
| Bupropion Xl | Bupropion Hcl | 74 | 22 |
| Amoxicillin | Amoxicillin | 73 | 48 |
| Ketoconazole | Ketoconazole | 73 | 32 |
| Benazepril Hcl | Benazepril Hcl | 71 | 22 |
| Memantine Hcl | Memantine Hcl | 71 | 19 |
| Spironolactone | Spironolactone | 71 | 19 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 69 | 23 |
| Ramipril | Ramipril | 69 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 68 | 21 |
| Verapamil Er | Verapamil Hcl | 66 | 17 |
| Hydralazine Hcl | Hydralazine Hcl | 65 | 21 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 65 | 14 |
| Cefdinir | Cefdinir | 64 | 49 |
| Citalopram Hbr | Citalopram Hydrobromide | 63 | 14 |
| Metformin Hcl Er | Metformin Hcl | 63 | 18 |
| Alendronate Sodium | Alendronate Sodium | 61 | 17 |
| Fenofibrate | Fenofibrate Nanocrystallized | 61 | 15 |
| Januvia | Sitagliptin Phosphate | 59 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 58 | 16 |
| Ipratropium Bromide | Ipratropium Bromide | 58 | 18 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 57 | 37 |
| Novolog Flexpen | Insulin Aspart | 57 | 16 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 57 | 18 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 56 | 11 |
| Fluconazole | Fluconazole | 55 | 32 |
| Fluticasone Propionate | Fluticasone Propionate | 55 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 55 | 16 |
| Clarithromycin | Clarithromycin | 54 | 37 |
| Glyxambi | Empagliflozin/Linagliptin | 54 | suppressed |
| Tradjenta | Linagliptin | 54 | 14 |
| Valacyclovir | Valacyclovir Hcl | 54 | 30 |
| Dicyclomine Hcl | Dicyclomine Hcl | 53 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 52 | 14 |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 52 | suppressed |
| Fluocinonide | Fluocinonide | 51 | 23 |
| Nystatin | Nystatin | 49 | 27 |
| Midodrine Hcl | Midodrine Hcl | 47 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 47 | suppressed |
| Trulicity | Dulaglutide | 46 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 46 | 13 |
| Metronidazole | Metronidazole | 45 | 27 |
| Mupirocin | Mupirocin | 45 | 24 |
| Pregabalin | Pregabalin | 45 | 14 |
| Promethazine Hcl | Promethazine Hcl | 45 | 32 |
| Tresiba Flextouch U-100 | Insulin Degludec | 45 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 44 | 12 |
| Cefuroxime | Cefuroxime Axetil | 43 | 38 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 43 | suppressed |
| Repaglinide | Repaglinide | 43 | 14 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 42 | 17 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 41 | suppressed |
| Lidocaine | Lidocaine | 41 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 40 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 40 | 13 |
| Nifedipine Er | Nifedipine | 40 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 39 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 39 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 39 | 18 |
| Digoxin | Digoxin | 38 | suppressed |
| Ibuprofen | Ibuprofen | 38 | suppressed |
| Myrbetriq | Mirabegron | 38 | 11 |
| Paxlovid | Nirmatrelvir/Ritonavir | 38 | 37 |
| Repatha Sureclick | Evolocumab | 38 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 37 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 37 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 36 | suppressed |
| Mounjaro | Tirzepatide | 36 | suppressed |
| Hydrocortisone | Hydrocortisone | 34 | suppressed |
| Lansoprazole | Lansoprazole | 34 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 34 | 22 |
| Oxybutynin Chloride | Oxybutynin Chloride | 34 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 34 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 33 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 33 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 33 | 12 |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 32 | suppressed |
| Celecoxib | Celecoxib | 32 | suppressed |
| Loperamide | Loperamide Hcl | 32 | suppressed |
| Metolazone | Metolazone | 32 | 11 |
| Propranolol Hcl | Propranolol Hcl | 32 | suppressed |
| Irbesartan | Irbesartan | 31 | suppressed |
| Ondansetron Odt | Ondansetron | 31 | 12 |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 31 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 30 | suppressed |
| Latanoprost | Latanoprost | 30 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 29 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 29 | suppressed |
| Jentadueto Xr | Linagliptin/Metformin Hcl | 29 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 29 | 11 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 28 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 28 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 28 | 22 |
| Ventolin Hfa | Albuterol Sulfate | 28 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 27 | suppressed |
| Carbamazepine Er | Carbamazepine | 26 | suppressed |
| Glyburide | Glyburide | 26 | suppressed |
| Levetiracetam | Levetiracetam | 26 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 25 | suppressed |
| Clotrimazole | Clotrimazole | 25 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 25 | suppressed |
| Entresto | Sacubitril/Valsartan | 24 | suppressed |
| Fenofibrate | Fenofibrate | 24 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 24 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 23 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 23 | suppressed |
| Dexamethasone | Dexamethasone | 23 | 17 |
| Labetalol Hcl | Labetalol Hcl | 23 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 23 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 23 | suppressed |
| Lovastatin | Lovastatin | 22 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 22 | suppressed |
| Primidone | Primidone | 22 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 22 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 22 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 22 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Gemfibrozil | Gemfibrozil | 21 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 21 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 21 | suppressed |
| Vascepa | Icosapent Ethyl | 21 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 20 | 12 |
| Diazepam | Diazepam | 20 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 20 | suppressed |
| Lamotrigine | Lamotrigine | 20 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 20 | 15 |
| Penicillin V Potassium | Penicillin V Potassium | 20 | suppressed |
| Armour Thyroid | Thyroid,pork | 19 | suppressed |
| Ciclopirox | Ciclopirox | 19 | suppressed |
| Rexulti | Brexpiprazole | 19 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 19 | suppressed |
| Ursodiol | Ursodiol | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 18 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 18 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Naproxen | Naproxen | 18 | suppressed |
| Silodosin | Silodosin | 18 | suppressed |
| Verapamil Sr | Verapamil Hcl | 18 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 17 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 17 | suppressed |
| Klor-Con M20 | Potassium Chloride | 17 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 17 | suppressed |
| Methimazole | Methimazole | 17 | suppressed |
| Methotrexate | Methotrexate Sodium | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 17 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 16 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 16 | suppressed |
| Folic Acid | Folic Acid | 16 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 16 | suppressed |
| Klor-Con M10 | Potassium Chloride | 16 | suppressed |
| Phenobarbital | Phenobarbital | 16 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 15 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 15 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 15 | suppressed |
| Jantoven | Warfarin Sodium | 15 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 15 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 15 | suppressed |
| Cevimeline Hcl | Cevimeline Hcl | 14 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Creon | Lipase/Protease/Amylase | 14 | suppressed |
| Edarbi | Azilsartan Medoxomil | 14 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 14 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 14 | suppressed |
| Telmisartan | Telmisartan | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 13 | suppressed |
| Nyamyc | Nystatin | 13 | suppressed |
| Verapamil Er Pm | Verapamil Hcl | 13 | suppressed |
| Balsalazide Disodium | Balsalazide Disodium | 12 | suppressed |
| Cefadroxil | Cefadroxil | 12 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 12 | suppressed |
| Indomethacin | Indomethacin | 12 | suppressed |
| Paxlovid (Eua) | Nirmatrelvir/Ritonavir | 12 | 12 |
| Calcitriol | Calcitriol | 11 | suppressed |
| Epinephrine | Epinephrine | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 11 | suppressed |
| Nystop | Nystatin | 11 | suppressed |
| Prolia | Denosumab | 11 | suppressed |
| Rybelsus | Semaglutide | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
| Trijardy Xr | Empaglifloz/Linaglip/Metformin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $47.17 · 2 records | Endo USA, Inc. | Ozempic, Rybelsus, XIAFLEX | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error